sb 202190 has been researched along with Eosinophilia, Tropical in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kampen, GT | 1 |
| Stafford, S | 1 |
| Adachi, T | 1 |
| Jinquan, T | 1 |
| Quan, S | 1 |
| Grant, JA | 1 |
| Skov, PS | 1 |
| Poulsen, LK | 1 |
| Alam, R | 1 |
1 other study available for sb 202190 and Eosinophilia, Tropical
| Article | Year |
|---|---|
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Degranulation; Chemokine CCL11; Chemokines, CC; C | 2000 |